Why it Matters

The Child Neurology Society ended a 21-year relationship with its previous lobbying firm. The organization switched to LobbyIt.com in July 2024. This marks a strategic shift toward a more diverse lobbying approach for pediatric neurology advocacy.

By the Numbers

  • The society has lobbied since 2003, filing 71 disclosures with Powers Pyles Sutter & Verville PC
  • LobbyIt.com assigned one lobbyist: Quardricos Bernard Driskell
  • The new registration covers “regulatory policy affecting pediatric neurology treatments and neurological research funding”
  • Previous lobbying focused on Health Issues and Budget/Appropriations

Broader Context

Congress is actively considering multiple pediatric healthcare bills this session. The Give Kids a Chance Act of 2025 would expand pediatric cancer drug development requirements. The Access to Pediatric Technologies Act of 2025 aims to improve payment for pediatric medical devices. These legislative efforts create new opportunities for specialized advocacy.

The Agenda

The society will lobby on regulatory policies affecting pediatric neurology treatments. They’re also focusing on neurological research funding. Previous efforts included physician loan programs, Medicare reimbursement policies, and federal research appropriations. The new firm’s diverse client base suggests broader policy connections.

Competitive Landscape

Multiple organizations compete for pediatric healthcare attention. Seattle Children’s Hospital and Texas Children’s Hospital lobby on similar workforce and funding issues. The Children’s Hospital Association advocates for pediatric hospitals broadly. Biotech firms like Denali Therapeutics push rare disease priorities.

Between The Lines

Bipartisan support exists for pediatric cancer research. Rep. Michael McCaul and Rep. Gus Bilirakis champion treatment development legislation. However, Democrats express concerns about NIH funding cuts. Rep. Mike Levin and Sen. Mazie Hirono advocate protecting pediatric brain cancer research funding. Rep. Kim Schrier works on pediatric subspecialist workforce development through the CHGME program.

The Bottom Line

The lobbying firm change signals a fresh advocacy approach for pediatric neurology. LobbyIt.com’s broader client base could open new policy connections.

All data used in this article came from Legis1. Request a demo to learn more!